ANURASAnupam Rasayan India Limited

Rs 1,124.5▲ +2.08%
Market closedEquity EOD 26 Oct
Compare
52-week rangeThe lowest and highest prices the stock traded at over the last year, from each day's intraday low and high. The marker is today's close: 0% means it sits at the year's low, 100% at the high. It describes where the price is, not where it is going.19.6% up the range
Rs 1,054Rs 1,415
ANURAS price
Daily candles, adjusted for splits and bonus issues so a corporate action does not show as a crash. Pick a window from one month to the full history, add indicators, or open it full screen.
EOD 26 Oct
IndicatorsVolume

Loading ANURAS price...

At a glance
Each figure is shown against the company's sector (the track: the dot is this company, the tick is the sector middle) and, where we hold the yearly filings, against its own recent years (the small trend line).
Market capWhat the whole company is worth on the stock market today: share price times the number of shares. It measures size, not quality.
Rs 12,802 cr
Larger than 83% of 64 peers
sector middle Rs 2,182 cr
P/EPrice to earnings: how many rupees investors pay for each rupee of profit the company made over the last twelve months. Compare it with similar companies rather than reading it alone.
73.1x
Higher than 86% of 56 peers
sector middle 26.9x
Price to bookPrice to book: the share price divided by the shareholders' money per share in the latest balance sheet. Around 1 means the market values the company close to its book value.
3.8x
Higher than 72% of 64 peers
sector middle 2.7x
ROEReturn on equity: the year's profit as a percentage of the shareholders' money in the business. It shows how much the company earns on what its owners have put in.
4.9%
Lower than 80% of 60 peers
sector middle 9.8%
FY23 8.6%FY26 4.8%
ROCEReturn on capital employed: operating profit as a percentage of all the long-term money in the business, owners' and lenders'. It shows how well the company uses its capital, whatever the mix of debt.
7.5%
Lower than 69% of 61 peers
sector middle 10.8%
FY23 12.4%FY26 7.5%
Debt to equityBorrowings divided by shareholders' money. 0 means no borrowings; 1 means it owes as much as its owners have put in. Not shown for banks and lenders, whose borrowing is their business.
0.39
Higher than 75% of 64 peers
sector middle 0.20
FY23 0.31FY26 0.39
Dividend yieldDividends paid over the last year as a percentage of the company's market value: roughly what Rs 100 of shares paid out in cash.
0.1%
Lower than 62% of 64 peers
sector middle 0.3%
Sales growthHow much the latest quarter's sales grew against the same quarter a year earlier.
+34.8%
Higher than 74% of 57 peers
sector middle +24.9%
FY23 45.9%FY26 64.4%

Peers are the listed companies in the exchange's own industry group: Specialty Chemicals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

What the numbers say
Short lines written by fixed rules from the company's own filings and shareholding. A line appears only when the figures cross the rule (for example sales growing three years running), and each names the numbers behind it. Nothing here is a view on whether to own the share.

Latest quarterIn the quarter to June 2026 (results filed 14 Aug 2026), sales rose 34.8% from a year earlier to Rs 655 cr and profit rose 5.7% to Rs 51.2 cr.

Worth watching
  • Operating margin fell from 26.8% in FY23 to 22.2% in FY26.
  • Return on equity stayed under 10% from FY24 to FY26 (highest 5.7%).

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

How the share moved on results
For each quarterly result we hold: the change from the share's close on the last trading day before the filing to its close on the first trading day after it. Results can land during market hours or after the close, and this window covers both. It shows what happened, not what will happen next time.

Over the last 20 results, the share rose on 5 and fell on 15, and moved by 3% or more on 6.

Q1 FY23Q1 FY24Q1 FY25Q1 FY26Q1 FY27

Q1 FY27: results filed 14 Aug 2026. The share went from its close on 13 Aug 2026 to its close on 17 Aug 2026 -0.90%.

Where every Rs 100 of sales goes
From the company's own yearly results. Each year is scaled to that year's sales, so you compare shares, not size: how much went on running costs, depreciation, interest and tax, and how much was left as profit.
5 financial years
Sales, last 12 months
Rs 2,535 Cr
Profit, last 12 months
Rs 225 Cr
Earnings per share
Rs 15.4
Profit growth (qtr, YoY)
+5.69%

Of every Rs 100 of sales in FY26, Rs 78 went on running costs, Rs 5.9 on depreciation, Rs 6.3 on interest and Rs 1.4 on tax; Rs 9.4 was left as profit.

FY22
72
14
FY23
73
14
FY24
74
11
FY25
72
7.1
7.8
11
FY26
78
9.4
Sales (Rs 100)Other incomeRunning costsDepreciationInterestTaxProfit

Thin bar: money in (sales plus other income). Thick bar: where it went. Each year is scaled to its own sales, so the bars compare shares, not size.

How fast it has grown
Compound growth per year in sales, profit and earnings per share between financial years, from the company's own results. A span appears only if our filings cover both ends of it.
Sales
3 yrs
+15.0%/yr
Latest qtr
+34.8%
Profit
3 yrs
+1.2%/yr
Latest qtr
+5.7%

Per year, compounded, between financial years FY26 and the year named; only spans our filings cover. The faint bar is the latest quarter against the same quarter a year earlier. Earnings per share is not shown: filed figures are not adjusted for bonus issues and splits, so its growth would mislead.

Health check, year by year
Margins, returns, debt and interest cover for each financial year. Each row is coloured against this company's own usual level, so you see what is improving and what is slipping.
MeasureFY22FY23FY24FY25FY26
Sales growthSales against the previous financial year.-45.9%-5.2%-2.5%64.4%
Operating marginProfit from operations, before depreciation, interest and tax, per Rs 100 of sales.27.9%26.8%25.8%28.0%22.2%
Net marginProfit after everything, per Rs 100 of sales.14.3%13.8%11.3%11.1%9.4%
ROEProfit as a percentage of shareholders' money (from the March balance sheet).-8.6%5.7%5.2%4.8%
ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'.-12.4%10.1%9.0%7.5%
Debt to equityBorrowings divided by shareholders' money. Lower is safer.-0.31x0.35x0.43x0.39x
Interest coverHow many times operating profit covers the interest bill. Higher is safer.8.2x5.8x3.7x2.8x2.7x

Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).

What it owns, and how that is paid for
Straight from the March balance sheet in the company's annual filing. Both bars are the whole balance sheet: what the company owns, and where the money for it came from.
as at 2026-03-31

At FY26 it owned Rs 8,013 Cr of assets. Its owners funded 58% of that and borrowings 23%.

What it owns
39%
9%
22%
12%
13%
Plant, property and projects3,094 Cr
Goodwill and intangibles733 Cr
Investments19 Cr
Inventory1,775 Cr
Owed by customers959 Cr
Cash and bank394 Cr
Everything else1,039 Cr
How that is paid for
58%
23%
12%
Shareholders4,630 Cr
Borrowings1,815 Cr
Owed to suppliers946 Cr
Other liabilities622 Cr
Cash and equivalents
Rs 378 Cr
Net debt
Rs 1,420 Cr
Current ratio
1.43x
short-term assets per rupee due soon
Book value / share
Rs 293
Return on assets
2.8%
EV / EBITDA
26.2x

From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.

Where the cash went
Profit is an accounting figure; cash flow is what actually moved. Cash from running the business, plus or minus what was spent on or received from investments, plus or minus what came from or went to lenders and shareholders, equals the change in cash.

In FY26 the business itself brought in Rs 334 Cr, spent Rs 555 Cr on plant and equipment, and cash rose by Rs 135 Cr over the year.

From running the business
+334 Cr
Spent on or received from investing
-820 Cr
From or to lenders and shareholders
+621 Cr
Net change in cash
+135 Cr
Cash from operations for every Rs 100 of profit
Rs 135
FY23
Rs 35
FY24
Rs -19
FY25
Rs 150
FY26

Rs 100 or more means every rupee of reported profit arrived as cash.

Full financial year to 2026-03-31, from the company's cash flow statement.

Against its sector
Where this stock sits within its own sector on each measure. The marker is its position in the peer group and the notch is the sector median. A position is a fact about the cohort, not a view on the stock.
Specialty Chemicals · 90
P/E73.11vs 26.92 median
Cheapest: PLASTIBLEN 10Priciest: OAL 647.47
Net margin8.88%vs 6.63% median
Lowest: DIAMINESQ -24.79%Highest: SUDEEPPHRM 27.18%
Revenue growth34.82%vs 24.93% median
Lowest: ALKALI -14.78%Highest: FCL 174.77%

Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.

Peers side by side
Every company in the same NSE industry group that we hold figures for, largest first. Tap any heading to sort by it. The same figures as the At a glance tiles, worked out the same way for every company.
Specialty Chemicals · 40 shown
Company
PIDILITIND
Pidilite Industries Limited
1.50 L cr56.9x13.9x24.2%28.5%0.0117.4%+21.3%1.01%
SRF
SRF Limited
69,362 cr30.4x4.5x14.9%-0.3412.5%+34.7%0.38%
FLUOROCHEM
Gujarat Fluorochemicals Limited
46,168 cr75.4x5.9x7.7%10.2%0.2811.5%+24.0%0.07%
NAVINFLUOR
Navin Fluorine International Limited
39,306 cr49.8x9.9x19.9%18.7%0.3121.7%+44.1%0.17%
DEEPAKNTR
Deepak Nitrite Limited
19,676 cr25.1x3.4x13.3%10.8%0.269.1%+36.4%0.52%
AETHER
Aether Industries Limited
19,529 cr82.8x8.0x9.6%12.2%0.1819.2%+52.4%0.00%
ATUL
Atul Limited
15,762 cr20.4x2.4x11.8%-0.0211.3%+20.9%0.47%
AARTIIND
Aarti Industries Limited
15,539 cr29.3x2.6x8.9%8.5%0.835.9%+42.5%0.23%
FINEORG
Fine Organic Industries Limited
15,328 cr35.0x5.8x16.4%20.2%0.0217.7%+18.0%0.22%
BASF
BASF India Limited
13,174 cr20.5x3.3x16.3%13.1%0.004.0%+24.5%0.66%
PRIVISCL
Privi Speciality Chemicals Limited
13,109 cr49.4x9.3x23.7%25.1%0.7012.8%+19.2%0.15%
ANURAS
Anupam Rasayan India Limited
12,802 cr73.1x3.8x4.9%7.5%0.398.9%+34.8%0.12%
SUDEEPPHRM
Sudeep Pharma Limited
11,103 cr59.7x12.6x20.4%24.2%0.1727.2%-0.00%
VINATIORGA
Vinati Organics Limited
10,964 cr24.4x3.5x14.2%17.7%0.0018.8%+28.4%0.71%
JUBLINGREA
Jubilant Ingrevia Limited
9,581 cr31.2x3.1x9.9%10.8%0.256.6%+25.3%0.83%
ALKYLAMINE
Alkyl Amines Chemicals Limited
8,373 cr37.2x5.5x14.7%14.6%0.0013.6%+30.2%0.61%
CLEAN
Clean Science and Technology Limited
7,835 cr33.6x5.0x14.7%19.2%0.0023.7%+10.5%0.81%
GALAXYSURF
Galaxy Surfactants Limited
7,710 cr21.8x2.8x12.9%12.7%0.066.2%+39.4%0.27%
NEOGEN
Neogen Chemicals Limited
5,955 cr163.7x7.3x4.4%6.8%1.633.8%+34.0%0.04%
BALAMINES
Balaji Amines Limited
5,882 cr28.7x3.0x9.8%10.2%0.0613.8%+27.2%0.61%
ACI
Archean Chemical Industries Limited
5,782 cr59.4x3.0x5.0%7.8%0.248.6%+11.9%0.64%
YASHO
Yasho Industries Limited
4,542 cr78.8x10.2x13.0%11.3%1.226.1%+54.9%0.01%
FOSECOIND
Foseco India Limited
4,285 cr42.6x4.0x9.4%-0.0013.2%+47.2%0.37%
LXCHEM
Laxmi Organic Industries Limited
4,257 cr33.9x2.1x6.3%4.4%0.274.0%+39.8%0.33%
EPIGRAL
Epigral Limited
3,820 cr14.1x1.7x12.2%14.8%0.2510.3%+16.3%0.48%
VISHNU
Vishnu Chemicals Limited
3,772 cr25.1x3.5x13.9%16.2%0.498.8%+24.9%0.05%
TATVA
Tatva Chintan Pharma Chem Limited
3,667 cr71.3x4.7x6.6%7.6%0.159.2%+43.0%0.06%
STYRENIX
Styrenix Performance Materials Limited
3,370 cr12.3x2.5x20.0%12.8%0.237.8%+7.1%2.80%
CHEMPLASTS
Chemplast Sanmar Limited
3,009 cr-1.7x-22.3%-4.1%1.11-9.2%+2.3%0.00%
JUBLCPL
Jubilant Agri and Consumer Products Limited
2,910 cr22.7x6.3x28.2%34.9%0.066.6%+18.4%0.00%
DDEVPLSTIK
Ddev Plastiks Industries Limited
2,473 cr11.6x2.4x21.1%28.9%0.056.7%+28.6%0.94%
NOCIL
NOCIL Limited
2,420 cr36.7x1.4x3.7%4.1%0.004.8%+19.9%1.40%
ROSSARI
Rossari Biotech Limited
2,251 cr14.9x1.7x11.3%15.3%0.315.9%+28.2%0.12%
OAL
Oriental Aromatics Limited
2,114 cr647.5x3.2x0.8%6.2%0.610.5%+15.2%0.08%
SHK
S H Kelkar and Company Limited
1,749 cr19.6x1.3x6.5%9.6%0.623.6%+14.1%1.58%
CAMLINFINE
Camlin Fine Sciences Limited
1,600 cr378.6x1.5x0.1%2.9%0.670.0%+22.7%0.00%
VIDHIING
Vidhi Specialty Food Ingredients Limited
1,557 cr29.2x4.8x16.2%20.9%0.1812.1%+66.4%1.45%
PAUSHAKLTD
Paushak Limited
1,501 cr-3.1x-8.7%0.16--0.40%
PLATIND
Platinum Industries Limited
1,242 cr24.6x2.8x10.8%14.9%0.0111.1%-5.6%0.00%
VALIANTORG
Valiant Organics Limited
1,221 cr22.5x1.6x7.2%7.0%0.337.1%+13.3%0.00%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

The business
Sales and net profit from the company's own filings, by financial year or by quarter. Hover any bar for that period's complete figures including operating margin and the change against the comparable earlier period. The single TTM figure above is the sum of the last four quarters.
5 years · 20 quarters
Full financial years - the long arc of the business.
Sales growth
+15.0%
a year, 3 years
Profit growth
+1.2%
a year, 3 years
Operating margin
22.2%
latest year
Sales by financial yearRs 2,366 Cr
Net profit by financial yearRs 222 Cr
FY225 full years · hover a yearFY26

Operating margin has gone from 27.9% to 22.2% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.

Dividends paid
Cash paid per share, from the exchange's corporate-action record, restated to today's share count across bonuses and splits. Dates shown are ex-dates: you must own the shares before that date to receive the payment.
0.13% yield
Rs 130 / year
Paid 5 of 6 yrs
on Rs 1 lakh at today's price · 0.13% yield · Rs 1.5/share
What each year paid, on Rs 1 lakh
89
36
133
67
133
21
22
23
24
25
26*
* 2026 so far - more may still be declared this year

2026 has paid Rs 1.50 per share, about Rs 133 on Rs 1 lakh at today's price. It skipped 1 of the last 6 years. Dividends are at the company's discretion and can be cut or skipped.

Large institutional deals
Bulk and block deals reported by the exchange, where a single large trade is disclosed along with the counterparty's name. Only deals above the exchange's disclosure threshold appear here.
last 2
DatePartySideQtyPriceValue
2026-09-21ASHAPURA COMMODITIESSELL15,02,1301,165.16Rs 175.02 Cr
2026-09-21360 ONE PIPE FUNDBUY9,00,0001,165Rs 104.85 Cr
Technical snapshot
Momentum, trend and delivery-based conviction from the actual price and volume history.
EOD 26 Oct
RSI (14) - momentum
42.9Neutral
0 oversold3070overbought 100
Delivery % - genuine buying vs churn
73.4%Near average
today 73.4%20d avg 60.2%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50-DMA
-5.85%
vs 200-DMA
-10.86%
1-month
-5.77%
3-month
-10.01%
1-year
-0.15%
Realized vol (30d)
36.3%
Insider trading disclosures
Promoter, director and other insider trades in the company's own shares, as disclosed to the exchange under SEBI's insider-trading regulations - usually within a few days of the transaction.
last 18 months

Insider trading data unavailable.

Recent announcements
The company's own filings to the exchange - results, board meetings, investor calls - with a link to the source document.
last 6 months

Announcements unavailable.

Want to test a strategy on ANURAS?

Backtest an equity strategy on real market data, free - no card needed.

Start free

Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.